These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37652354)

  • 1. Integrative data analysis of clinical trials network studies to examine the impact of psychosocial treatments for black people who use cocaine: Study protocol.
    Haeny AM; McCuistian C; Burlew AK; Ruglass LM; Espinosa A; Jordan A; Roundtree C; Lopez J; Morgan-López AA
    Contemp Clin Trials; 2023 Oct; 133():107329. PubMed ID: 37652354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups - United States, 2004-2019.
    Kariisa M; Seth P; Scholl L; Wilson N; Davis NL
    Drug Alcohol Depend; 2021 Oct; 227():109001. PubMed ID: 34492555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis.
    De Crescenzo F; Ciabattini M; D'Alò GL; De Giorgi R; Del Giovane C; Cassar C; Janiri L; Clark N; Ostacher MJ; Cipriani A
    PLoS Med; 2018 Dec; 15(12):e1002715. PubMed ID: 30586362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.
    Montgomery L; Burlew AK; Haeny AM; Jones CA
    Psychol Addict Behav; 2020 Feb; 34(1):117-127. PubMed ID: 31246072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors associated with psychostimulant use among Black individuals: A meta-analysis and systematic review.
    Cénat JM; Kogan CS; Kebedom P; Ukwu G; Moshirian Farahi SMM; Darius WP; Mulopo Bakombo S; Dalexis RD; Ndengeyingoma A; Noorishad PG; Labelle PR
    Addict Behav; 2023 Mar; 138():107567. PubMed ID: 36521424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Fairgrieve C; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009269. PubMed ID: 30521696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999-2018.
    Rawy M; Abdalla G; Look K
    BMC Public Health; 2024 Jan; 24(1):112. PubMed ID: 38184563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable efficacy of behavioral and pharmacological treatments among African American and White cocaine users.
    Montgomery L; Carroll KM
    J Ethn Subst Abuse; 2017; 16(4):445-459. PubMed ID: 28441119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates and influences of alcohol use disorder comorbidity among primary stimulant misusing treatment-seekers: meta-analytic findings across eight NIDA CTN trials.
    Hartzler B; Donovan DM; Huang Z
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):460-71. PubMed ID: 21854291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis.
    Estadt AT; White BN; Ricks JM; Lancaster KE; Hepler S; Miller WC; Kline D
    Harm Reduct J; 2024 Jan; 21(1):13. PubMed ID: 38233924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of psychosocial interventions for reducing parental substance misuse.
    McGovern R; Newham JJ; Addison MT; Hickman M; Kaner EF
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012823. PubMed ID: 33723860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
    Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
    Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
    Hoots B; Vivolo-Kantor A; Seth P
    Addiction; 2020 May; 115(5):946-958. PubMed ID: 31912625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sociodemographic and clinical outcome differences among individuals seeking treatment for cocaine use disorders. The intersection of gender and race.
    Miguel AQC; Jordan A; Kiluk BD; Nich C; Babuscio TA; Mari JJ; Carroll KM
    J Subst Abuse Treat; 2019 Nov; 106():65-72. PubMed ID: 31540613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study.
    Wu LT; Pan JJ; Blazer DG; Tai B; Stitzer ML; Woody GE
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S70-9. PubMed ID: 20307798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.
    Lindblad R; Hu L; Oden N; Wakim P; Rosa C; VanVeldhuisen P
    J Subst Abuse Treat; 2016 Nov; 70():73-80. PubMed ID: 27692192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.